Anti-CXCR5 antibody(Centivax)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-CXCR5 antibody(Centivax)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionC-X-C motif chemokine receptor 5 antagonists
TargetsC-X-C motif chemokine receptor 5
Therapy Area/IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDistributed In France By
China Registration ClassN/A

Develop Information

Active CompaniesDistributed In France By
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A